Company engaged a starring objective halfway successful Israel and intends to behaviour its first- in- quality proceedings successful the United States arsenic good
Tel Aviv, Israel / Vancouver, Canada, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” oregon the "company"), a biotech institution focused connected find and improvement of caller psychedelic-derived therapeutics to lick large under-treated wellness problems, has announced the archetypal statement to behaviour its first- in-human objective proceedings utilizing its MEAI-based CMND-100 compound aimed astatine treating intoxicant usage upset ("AUD").
The statement was signed with the Phase I/II portion astatine the IMCA halfway successful Ramat Gan, Israel. The proceedings volition beryllium led by Prof. Mark Weiser, caput of the Psychiatric Division astatine the Sheba Medical Center, whose specializations see cognitive impairment successful persons with psychiatric disorders specified arsenic substance abuse, slump and property disorders.
"We are thrilled to person the archetypal objective halfway articulation our objective proceedings and pleased that our innovative attack to treating AUD is well-received by the aesculapian community. It is our volition to motion a akin statement with a objective halfway successful the United States. We’re committed to moving with starring researchers and aesculapian professionals to bring caller and effectual treatments to patients suffering the physical, intelligence and societal repercussions of psychiatric disorders.” said Dr. Adi Zuloff-Shani, Clearmind's CEO.
Prof. Mark Weiser stated, "AUD is precise damaging to the idiosyncratic and her/his family. Because it is truthful common, it has large implications for nationalist health. CMND-100 has large imaginable to alleviate this debilitating disorder, and amended the prime of beingness of millions of persons each implicit the world. This objective survey is simply a important measurement foreword successful processing CMND-100, and I americium blessed to beryllium portion of it.”
Almost 28 cardinal radical implicit 18 years of property struggled with intoxicant usage successful the U.S. unsocial successful 2020, according to the National Survey On Drug Use And Health. The information is astir terrible among the young: successful the 18-25 property group, 15.6 percent (or 5.2 cardinal people) had AUD compared to 10.3 percent (or 22.4 cardinal people) among those implicit 25.
According to DelveInsight, the Alcohol Use Disorder attraction marketplace size successful the U.S., Italy, Spain, UK, Germany, France and Japan was $564 cardinal successful 2021, which is further expected to summation by 8.8% until 2032. A caller Organization for Economic Co-operation and Development (“OECD”) survey showed that OECD countries suffer astir $595 cardinal PPP (Purchasing Power Parity) per year, resulting from precocious intoxicant depletion (over 12 grams of intoxicant a time for women and 18 grams a time for men). The economical nonaccomplishment results from missing labour days, related diseases, and different derivatives of excessive intoxicant use.
About Clearmind Medicine Inc.
Clearmind is simply a psychedelic pharmaceutical biotech institution focused connected the find and improvement of caller psychedelic-derived therapeutics to lick wide and underserved wellness problems, including intoxicant usage disorder. Its superior nonsubjective is to probe and make psychedelic-based compounds and effort to commercialize them arsenic regulated medicines, foods oregon supplements.
The company’s intelligence portfolio presently consists of 7 patent families. The institution intends to question further patents for its compounds whenever warranted and volition stay opportunistic regarding the acquisition of further intelligence spot to physique its portfolio.
Shares of Clearmind are listed for trading connected Nasdaq and the Canadian Securities Exchange nether the awesome "CMND" and the Frankfurt Stock Exchange nether the awesome “CWY”.
For further accusation visit: https://www.clearmindmedicine.com or contact:
Investor Relations
invest@clearmindmedicine.com
Telephone: (604) 260-1566
General Inquiries
Info@Clearmindmedicine.com
www.Clearmindmedicine.com
FORWARD-LOOKING STATEMENTS:
This property merchandise contains “forward-looking statements” wrong the meaning of the Private Securities Litigation Reform Act and different securities laws. Words specified arsenic “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates” and akin expressions oregon variations of specified words are intended to place forward-looking statements. For example, the Company is utilizing forward-looking statements erstwhile it discusses conducting its first- in-human objective trial, its volition to motion an statement with a objective halfway successful the United States, its committedness to moving with starring researchers and aesculapian professionals to bring caller and effectual treatments to patients suffering the physical, intelligence and societal repercussions of psychiatric disorders, and that psychedelic based treatments clasp imaginable to code and supply dedicated solutions for assorted intelligence wellness conditions. Forward-looking statements are not humanities facts, and are based upon management’s existent expectations, beliefs and projections, galore of which, by their nature, are inherently uncertain. Such expectations, beliefs and projections are expressed successful bully faith. However, determination tin beryllium nary assurance that management’s expectations, beliefs and projections volition beryllium achieved, and existent results whitethorn disagree materially from what is expressed successful oregon indicated by the forward-looking statements. Forward-looking statements are taxable to risks and uncertainties that could origin existent show oregon results to disagree materially from those expressed successful the forward-looking statements. For a much elaborate statement of the risks and uncertainties affecting the Company, notation is made to the Company’s reports filed from clip to clip with the Securities and Exchange Commission (“SEC”), including, but not constricted to, the risks elaborate successful the Company’s last prospectus (registration No. 333-265900) filed with the SEC connected November 16, 2022. Forward-looking statements talk lone arsenic of the day the statements are made. The Company assumes nary work to update forward-looking statements to bespeak existent results, consequent events oregon circumstances, changes successful assumptions oregon changes successful different factors affecting forward-looking accusation but to the grade required by applicable securities laws. If the Company does update 1 oregon much forward-looking statements, nary inference should beryllium drawn that the Company volition marque further updates with respect thereto oregon with respect to different forward-looking statements. References and links to websites person been provided arsenic a convenience, and the accusation contained connected specified websites is not incorporated by notation into this property release. Clearmind is not liable for the contents of third-party websites.
English (US)